NO892059D0 - Fremgangsmaate for fremstilling av aromatiske og heterocykliske karboksamid-derivater. - Google Patents

Fremgangsmaate for fremstilling av aromatiske og heterocykliske karboksamid-derivater.

Info

Publication number
NO892059D0
NO892059D0 NO892059A NO892059A NO892059D0 NO 892059 D0 NO892059 D0 NO 892059D0 NO 892059 A NO892059 A NO 892059A NO 892059 A NO892059 A NO 892059A NO 892059 D0 NO892059 D0 NO 892059D0
Authority
NO
Norway
Prior art keywords
aromatic
procedure
preparation
carboxamide derivatives
heterocyclic carboxamide
Prior art date
Application number
NO892059A
Other languages
English (en)
Other versions
NO892059L (no
NO172389B (no
NO172389C (no
Inventor
Anton Franz Josef Fliri
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO892059D0 publication Critical patent/NO892059D0/no
Publication of NO892059L publication Critical patent/NO892059L/no
Publication of NO172389B publication Critical patent/NO172389B/no
Publication of NO172389C publication Critical patent/NO172389C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Graft Or Block Polymers (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO892059A 1988-05-24 1989-05-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler NO172389C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19803488A 1988-05-24 1988-05-24

Publications (4)

Publication Number Publication Date
NO892059D0 true NO892059D0 (no) 1989-05-23
NO892059L NO892059L (no) 1989-11-27
NO172389B NO172389B (no) 1993-04-05
NO172389C NO172389C (no) 1993-07-14

Family

ID=22731735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892059A NO172389C (no) 1988-05-24 1989-05-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler

Country Status (25)

Country Link
EP (1) EP0343893B1 (no)
JP (1) JPH0678331B2 (no)
KR (1) KR910006864B1 (no)
CN (1) CN1023700C (no)
AT (1) ATE79114T1 (no)
AU (1) AU601905B2 (no)
CA (1) CA1328871C (no)
DD (1) DD283815A5 (no)
DE (1) DE68902358T2 (no)
DK (1) DK249389A (no)
ES (1) ES2043012T3 (no)
FI (1) FI892498A (no)
GR (1) GR3005844T3 (no)
HU (1) HU202507B (no)
IE (1) IE891667L (no)
IL (1) IL90337A0 (no)
MX (1) MX173140B (no)
MY (1) MY106035A (no)
NO (1) NO172389C (no)
NZ (1) NZ229234A (no)
PL (1) PL154875B1 (no)
PT (1) PT90622B (no)
SU (1) SU1681728A3 (no)
YU (1) YU47019B (no)
ZA (1) ZA893862B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2790299B2 (ja) * 1989-02-01 1998-08-27 保土谷化学工業株式会社 ペンゾチアゾール誘導体
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
JPH11510814A (ja) 1995-08-30 1999-09-21 ジー．ディー．サール アンド カンパニー インテグリンアンタゴニストとしてのメタ−グアニジン、尿素、チオ尿素またはアザ環状アミノ安息香酸誘導体
US5716281A (en) * 1995-11-27 1998-02-10 Sega Enterprises, Ltd. Game apparatus using a vehicle with an optical image synthesizing system
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
EP1037632B1 (en) 1997-11-10 2006-01-11 Bristol-Myers Squibb Company Benzothiazole protein tyrosine kinase inhibitors
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
AU3406599A (en) * 1998-04-09 1999-11-01 Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin Novel benzyl guanidine derivatives for therapy and (in-vivo) and (in-vitro) diagnosis
ATE385794T1 (de) 2000-06-21 2008-03-15 Hoffmann La Roche Benzothiazolderivate zur behandlung von alzheimer und parkinson
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
CN100357283C (zh) * 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
EP1753760B1 (en) 2004-05-24 2008-01-02 F.Hoffmann-La Roche Ag 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
CA2586931C (en) 2004-11-05 2013-08-06 Paul Spurr Process for preparation of isonicotinic acid derivatives
KR100973609B1 (ko) 2005-03-23 2010-08-03 에프. 호프만-라 로슈 아게 ｍＧｌｕＲ2 길항제로서 아세틸렌일-피라졸로-피리미딘유도체
WO2007039439A1 (en) 2005-09-27 2007-04-12 F.Hoffmann-La Roche Ag Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists
CN101405278A (zh) * 2006-03-15 2009-04-08 4Sc股份公司 新颖的杂环NF-κB抑制剂
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
EP2303886A2 (en) * 2008-06-24 2011-04-06 Takeda Pharmaceutical Company Limited Pi3k/m tor inhibitors
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
WO2013049407A2 (en) * 2011-09-30 2013-04-04 Kineta, Inc Anti-viral compounds
KR101996343B1 (ko) 2012-01-27 2019-07-05 고쿠리츠 다이가쿠 호진 교토 다이가쿠 전능성 줄기세포의 심근분화 유도방법
EP2966166B1 (en) 2013-03-08 2019-04-03 Kyoto University Promoter of differentiation of pluripotent stem cell into myocardium, which comprises egf receptor inhibitor
WO2015037706A1 (ja) * 2013-09-13 2015-03-19 国立大学法人京都大学 多能性幹細胞の心筋分化を促進する化合物
WO2015182765A1 (ja) 2014-05-30 2015-12-03 国立大学法人京都大学 低分子化合物を用いた多能性幹細胞の心筋分化誘導法
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN110590735B (zh) * 2019-09-30 2021-07-23 江苏国泰超威新材料有限公司 一种环状硫酸酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225168A (ja) * 1985-03-30 1986-10-06 Nippon Tokushu Noyaku Seizo Kk 新規ベンズアミド、その製法及び殺虫剤
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8611606D0 (en) * 1986-05-13 1986-06-18 Fbc Ltd Fungicides

Also Published As

Publication number Publication date
EP0343893A1 (en) 1989-11-29
MX16158A (es) 1993-06-01
DE68902358D1 (de) 1992-09-10
CA1328871C (en) 1994-04-26
KR890017248A (ko) 1989-12-15
CN1037898A (zh) 1989-12-13
SU1681728A3 (ru) 1991-09-30
NZ229234A (en) 1990-09-26
DE68902358T2 (de) 1992-12-10
DK249389D0 (da) 1989-05-23
PL279613A1 (en) 1989-11-27
ES2043012T3 (es) 1993-12-16
YU105989A (en) 1990-08-31
PT90622A (pt) 1989-11-30
FI892498A0 (fi) 1989-05-23
EP0343893B1 (en) 1992-08-05
YU47019B (sh) 1994-11-15
AU3509889A (en) 1989-11-30
HUT51606A (en) 1990-05-28
ZA893862B (en) 1991-01-30
HU202507B (en) 1991-03-28
NO892059L (no) 1989-11-27
FI892498A (fi) 1989-11-25
AU601905B2 (en) 1990-09-20
MY106035A (en) 1995-03-31
GR3005844T3 (no) 1993-06-07
NO172389B (no) 1993-04-05
JPH0217181A (ja) 1990-01-22
PT90622B (pt) 1994-10-31
PL154875B1 (en) 1991-09-30
JPH0678331B2 (ja) 1994-10-05
MX173140B (es) 1994-02-02
CN1023700C (zh) 1994-02-09
ATE79114T1 (de) 1992-08-15
DK249389A (da) 1989-11-27
IE891667L (en) 1989-11-24
NO172389C (no) 1993-07-14
KR910006864B1 (ko) 1991-09-09
DD283815A5 (de) 1990-10-24
IL90337A0 (en) 1989-12-15

Similar Documents

Publication Publication Date Title
NO892059D0 (no) Fremgangsmaate for fremstilling av aromatiske og heterocykliske karboksamid-derivater.
NO880740D0 (no) Fremgangsmaate for fremstilling av mettede heterocykliske carboxamidderivater.
NO861481L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive heterocykliske amid-derivater.
LU90944I2 (fr) Dérivés pipérazinyl-héterocycliques
MC1921A1 (fr) Derives acyles
MC1970A1 (fr) Derives acyles
IT8721977A0 (it) Derivati ammidinici
MC1920A1 (fr) Derives acyles
ES557389A0 (es) Procedimiento para preparar 1,2-dihidronaftalenos y derivados 1-oxa, 1-tia 1-sulfinilo y 1-sulfonilo de los mismos
MC2000A1 (fr) Derives acyles
DE3471482D1 (de) Amide derivatives of azabicycloalkanes
MC1952A1 (fr) Derives acyles
DE3852245D1 (de) Isoprenderivate und diese enthaltende Anti-Ulcus-Mittel.
IT1227695B (it) Procedimento per la reversione della tossicita' della bromovinildesossiuridina (bvudr)
ES540773A0 (es) Procedimiento de obtencion de derivados de 1,4-dihidropiri- dina
ES550381A0 (es) Procedimiento de obtencion de derivados de carboxamidas de 1,2-benzotiazina
NO874739L (no) Fremgangsmaate for fremstilling av amorfe benzimidazolderivater med forbedret opploeselighet og anthelmintisk aktivitet.
NO880083D0 (no) Fremgangsmaate for fremstilling av amorfe benzimidazolderivater med forbedret opploeselighet og anthelmintisk aktivitet.
NO881861D0 (no) Fremgangsmaate for fremstilling av amorfe benzimidazolderivater med forbedret opploeselighet og anthelmintisk aktivitet.
NO881862D0 (no) Fremgangsmaate for fremstilling av amorfe benzimidazolderivater med forbedret opploeselighet og anthelmintisk aktivitet.
NO922253D0 (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater
NO172488C (no) Framgangsmaate for framstilling av 1,5-benzotiazepinderivater